Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Significant Decrease in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 883 shares, a drop of 36.1% from the January 29th total of 1,382 shares. Based on an average daily volume of 2,916 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 2,916 shares, the days-to-cover ratio is presently 0.3 days.

Cardio Diagnostics Stock Down 40.9%

Cardio Diagnostics stock traded down $0.02 during trading on Monday, reaching $0.03. The stock had a trading volume of 151,106 shares, compared to its average volume of 79,172. The business has a 50 day moving average price of $0.02 and a 200 day moving average price of $0.02. Cardio Diagnostics has a 52-week low of $0.01 and a 52-week high of $0.07.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.